Literature DB >> 33711334

The regulation of RNA metabolism in hormone signaling and breast cancer.

Xiaofei Wang1, Da Yang2.   

Abstract

As the most frequent women's cancer, breast cancer causes the second most cancer-related death in women worldwide. Majority of the breast cancers are hormone receptor-positive and commonly treated by hormone therapy. Thus, the expression levels of hormone receptors signaling pathways are pivotal in the development and therapy of breast cancer. The expression of hormone receptors signaling pathways is not only regulated at the transcription level but also at the post-transcription level by both proteins and RNAs. In addition to that, the function of hormone receptors can also be regulated by RNAs. In this review, we summarize the roles of RNAs in hormone receptor-positive breast cancer. We introduce how mRNA stability and protein function of genes in hormone receptors signaling pathways are regulated by RNA-binding proteins, miRNAs, and lncRNAs. We believe these proteins and RNAs can be potential therapeutic targets of breast cancer.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Breast cancer; Hormone receptor; Hormone therapy; RNA metabolism; lncRNA; miRNA

Mesh:

Substances:

Year:  2021        PMID: 33711334      PMCID: PMC8262629          DOI: 10.1016/j.mce.2021.111221

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  43 in total

1.  Targeting a KH-domain protein with RNA decoys.

Authors:  Aleksandr V Makeyev; Dawn L Eastmond; Stephen A Liebhaber
Journal:  RNA       Date:  2002-09       Impact factor: 4.942

2.  Trichostatin A and 5 Aza-2' deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR.

Authors:  Peter Pryzbylkowski; Oluwakemi Obajimi; Judith Clancy Keen
Journal:  Breast Cancer Res Treat       Date:  2007-09-21       Impact factor: 4.872

Review 3.  Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (review).

Authors:  Rubí Viedma-Rodríguez; Luis Baiza-Gutman; Fabio Salamanca-Gómez; Mariana Diaz-Zaragoza; Guadalupe Martínez-Hernández; Ruth Ruiz Esparza-Garrido; Miguel Angel Velázquez-Flores; Diego Arenas-Aranda
Journal:  Oncol Rep       Date:  2014-05-16       Impact factor: 3.906

Review 4.  Nucleo-cytoplasmic transport of estrogen receptor alpha in breast cancer cells.

Authors:  Angeles C Tecalco-Cruz; Issis A Pérez-Alvarado; Josué O Ramírez-Jarquín; Leticia Rocha-Zavaleta
Journal:  Cell Signal       Date:  2017-03-22       Impact factor: 4.315

5.  MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.

Authors:  J Cui; Y Yang; H Li; Y Leng; K Qian; Q Huang; C Zhang; Z Lu; J Chen; T Sun; R Wu; Y Sun; H Song; X Wei; P Jing; X Yang; C Zhang
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

6.  Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer.

Authors:  Dawn R Cochrane; Britta M Jacobsen; Keith D Connaghan; Erin N Howe; David L Bain; Jennifer K Richer
Journal:  Mol Cell Endocrinol       Date:  2012-01-18       Impact factor: 4.102

7.  Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: a novel function for SR proteins.

Authors:  Raphael Lemaire; Jayendra Prasad; Tsuyoshi Kashima; Jennifer Gustafson; James L Manley; Robert Lafyatis
Journal:  Genes Dev       Date:  2002-03-01       Impact factor: 11.361

8.  The alternative noncoding exons 1 of aromatase (Cyp19) gene modulate gene expression in a posttranscriptional manner.

Authors:  Hanzhou Wang; Rong Li; Yanfen Hu
Journal:  Endocrinology       Date:  2009-03-12       Impact factor: 4.736

Review 9.  Emerging Evidence of Translational Control by AU-Rich Element-Binding Proteins.

Authors:  Hiroshi Otsuka; Akira Fukao; Yoshinori Funakami; Kent E Duncan; Toshinobu Fujiwara
Journal:  Front Genet       Date:  2019-05-02       Impact factor: 4.599

10.  Expression profile analysis of long noncoding RNA in ER-positive subtype breast cancer using microarray technique and bioinformatics.

Authors:  Jing Peng; Lei Zhang; Chenwei Yuan; Liheng Zhou; Shuguang Xu; Yanping Lin; Jie Zhang; Wenjin Yin; Jinsong Lu
Journal:  Cancer Manag Res       Date:  2017-12-14       Impact factor: 3.989

View more
  1 in total

Review 1.  Emerging Roles and Mechanisms of lncRNA FOXD3-AS1 in Human Diseases.

Authors:  Qinfan Yao; Xiuyuan Zhang; Dajin Chen
Journal:  Front Oncol       Date:  2022-02-25       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.